{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:50:48Z","timestamp":1791240648326,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1378\/chest.14-3095","type":"journal-article","created":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T13:30:51Z","timestamp":1426771851000},"page":"444-449","source":"Crossref","is-referenced-by-count":23,"title":["Lymphangioleiomyomatosis and Tuberous Sclerosis Complex in Quebec"],"prefix":"10.1016","volume":"148","author":[{"given":"Arnold S.","family":"Kristof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhi Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1378\/chest.14-3095_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1378\/chest.14-3095_bib2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0733-8619(03)00004-5","article-title":"Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases","volume":"21","author":"Kandt","year":"2003","journal-title":"Neurol Clin"},{"issue":"9639","key":"10.1378\/chest.14-3095_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1378\/chest.14-3095_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1378\/chest.14-3095_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm.164.4.2101154","article-title":"Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex","volume":"164","author":"Moss","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.14-3095_bib6","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1378\/chest.12-2813","article-title":"Lymphangioleiomyomatosis screening in women with tuberous sclerosis","volume":"144","author":"Cudzilo","year":"2013","journal-title":"Chest"},{"issue":"8","key":"10.1378\/chest.14-3095_bib7","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1185\/03007995.2011.586687","article-title":"Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review","volume":"27","author":"Hallett","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1378\/chest.14-3095_bib8","author":"Cadre normatif du syst\u00e8me MED-\u00c9CHO"},{"key":"10.1378\/chest.14-3095_bib9","author":"Minist\u00e8re de la Sant\u00e9 et des Services Sociaux du Qu\u00e9bec"},{"issue":"8","key":"10.1378\/chest.14-3095_bib10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0895-4356(94)00234-H","article-title":"The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Qu\u00e9bec","volume":"48","author":"Tamblyn","year":"1995","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1378\/chest.14-3095_bib11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1164\/rccm.200503-483OE","article-title":"Clinical advances in the diagnosis and therapy of the interstitial lung diseases","volume":"172","author":"King","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.14-3095_bib12","series-title":"Statistical Methods in Medical Research","author":"Armitage","year":"2005"},{"issue":"4","key":"10.1378\/chest.14-3095_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1378\/chest.14-3095_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0032-1325159","article-title":"Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment","volume":"33","author":"Meraj","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1378\/chest.14-3095_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1183\/09031936.00076209","article-title":"European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis","volume":"35","author":"Johnson","year":"2010","journal-title":"Eur Respir J"},{"issue":"17","key":"10.1378\/chest.14-3095_bib16","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1378\/chest.14-3095_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2014.10.028","article-title":"Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy","volume":"52","author":"Curatolo","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1378\/chest.14-3095_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2213-2600(13)70090-0","article-title":"Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial","volume":"1","author":"Young","year":"2013","journal-title":"Lancet Respir Med."}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215503413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215503413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T02:03:18Z","timestamp":1616119398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215503413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0012369215503413"],"URL":"https:\/\/doi.org\/10.1378\/chest.14-3095","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}